NKG2D ligands:: key targets of the immune response

被引：204

作者：

Gonzalez, Segundo ^{[2
]}

Lopez-Soto, Alejandro ^{[2
]}

Suarez-Alvarez, Beatriz ^{[1
]}

Lopez-Vazquez, Antonio ^{[1
]}

Lopez-Larrea, Carlos ^{[1
,3
]}

机构：

[1] Hosp Univ Cent Asturias, Dept Immunol, Oviedo 33006, Spain

[2] Univ Oviedo, Dept Funct Biol, IUOPA, E-33006 Oviedo, Spain

[3] Fdn Renal Inigo Alvarez Toledo, Madrid 28003, Spain

来源：

TRENDS IN IMMUNOLOGY | 2008年 / 29卷 / 08期

关键词：

D O I：

10.1016/j.it.2008.04.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

NKG2D is an activating receptor expressed by NK and T cells. NKG2D ligands show a restricted expression in normal tissues, but they are frequently overexpressed in cancer and infected cells. The binding of NKG2D to its ligands activates NK and T cells and promotes cytotoxic lysis of the cells expressing these molecules. The mechanisms involved in the expression of the ligands of NKG2D play a key role in the recognition of stressed cells by the immune system and represent a promising therapeutic target for improving the immune response against cancer or autoimmune disease. In this review, we analyse the recent advances in understanding the regulation of NKG2D ligand expression and their therapeutic implications.

引用

页码：397 / 403

页数：7

共 72 条

[11] Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A [J].

Busche, A ;

Goldmann, T ;

Naumann, U ;

Steinle, A ;

Brandau, S .

HUMAN GENE THERAPY, 2006, 17 (02) :135-146

[12] HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells [J].

Carbone, E ;

Neri, P ;

Mesuraca, M ;

Fulciniti, MT ;

Otsuki, T ;

Pende, D ;

Groh, V ;

Spies, T ;

Pollio, G ;

Cosman, D ;

Catalano, L ;

Tassone, P ;

Rotoli, B ;

Venuta, S .

BLOOD, 2005, 105 (01) :251-258

[13] The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation [J].

Cebo, C ;

Da Rocha, S ;

Wittnebel, S ;

Turhan, AG ;

Abdelali, J ;

Caillat-Zucman, S ;

Bourhis, JH ;

Chouaib, S ;

Caignard, A .

JOURNAL OF IMMUNOLOGY, 2006, 176 (02) :864-872

[14] Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis [J].

Cerboni, Cristina ;

Zingoni, Alessandra ;

Cippitelli, Marco ;

Piccoli, Mario ;

Frati, Luigi ;

Santoni, Angela .

BLOOD, 2007, 110 (02) :606-615

[15] Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity [J].

Cerboni, Cristina ;

Neri, Francesca ;

Casartelli, Nicoletta ;

Zingoni, Alessandra ;

Cosman, David ;

Rossi, Paolo ;

Santoni, Angela ;

Doria, Margherita .

JOURNAL OF GENERAL VIROLOGY, 2007, 88 :242-250

[16] Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo [J].

Cerwenka, A ;

Baron, JL ;

Lanier, LL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11521-11526

[17] Ligands for natural killer cell receptors: redundancy or specificity [J].

Cerwenka, A ;

Lanier, LL .

IMMUNOLOGICAL REVIEWS, 2001, 181 :158-169

[18] Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142 [J].

Chalupny, NJ ;

Rein-Weston, A ;

Dosch, S ;

Cosman, D .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (01) :175-181

[19] ULBP4 is a novel ligand for human NKG2D [J].

Chalupny, NJ ;

Sutherland, CL ;

Lawrence, WA ;

Rein-Weston, A ;

Cosman, D .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (01) :129-135

[20] ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor [J].

Cosman, D ;

Müllberg, J ;

Sutherland, CL ;

Chin, W ;

Armitage, R ;

Fanslow, W ;

Kubin, M ;

Chalupny, NJ .

IMMUNITY, 2001, 14 (02) :123-133

← 1 2 3 4 5 6 7 8 →